DCM
WVE icon

Driehaus Capital Management’s Wave Life Sciences WVE Stock Holding History

Driehaus Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6M Buy
5,443,143
+12,122
+0.2% +$80.4K 0.18% 172
2026
Q1 		$39.4M Sell
5,431,021
-1,150,046
-17% -$15M 0.29% 120
2025
Q4 		$112M Buy
6,581,067
+283,007
+4% +$2.88M 0.76% 28
2025
Q3 		$46.1M Sell
6,298,060
-233,459
-4% -$1.89M 0.33% 98
2025
Q2 		$42.5M Buy
6,531,519
+172,920
+3% +$1.14M 0.34% 96
2025
Q1 		$51.4M Sell
6,358,599
-353,850
-5% -$3.87M 0.5% 59
2024
Q4 		$83M Buy
6,712,449
+853,589
+15% +$11.4M 0.69% 30
2024
Q3 		$48M Buy
5,858,860
+4,950,764
+545% +$29.6M 0.41% 82
2024
Q2 		$4.53M Buy
908,096
+348,300
+62% +$1.99M 0.04% 266
2024
Q1 		$3.45M Sell
559,796
-27,779
-5% -$139K 0.03% 288
2023
Q4 		$2.97M Buy
+587,575
New +$3.14M 0.04% 284
2018
Q2 		– Sell
-69,299
Closed -$2.78M – 572
2018
Q1 		$2.78M Buy
+69,299
New +$2.91M 0.1% 219

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Driehaus Capital Management's WVE Position: Q2 2026 in Review

Driehaus Capital Management increased its Wave Life Sciences (WVE) stake by 0.22% in Q2 2026, buying an estimated $80.4K and bringing the position to 5,443,143 shares worth $31.6M. The position accounts for 0.18% of the portfolio, ranked #172.

Driehaus Capital Management first reported a position in WVE in Q1 2018 and has held it in 12 quarters since. The position peaked at $112M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Driehaus Capital Management held 5,443,143 shares of Wave Life Sciences worth $31.6M as of Q2 2026.
  • Driehaus Capital Management bought 12,122 Wave Life Sciences shares in Q2 2026, an estimated $80.4K.
  • Wave Life Sciences made up 0.18% of Driehaus Capital Management's portfolio in Q2 2026, its #172 holding.
  • Driehaus Capital Management first reported a position in Wave Life Sciences in Q1 2018 and has held it in 12 quarters since.
  • Driehaus Capital Management's Wave Life Sciences position peaked at $112M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.